Dashboard
Poor Management Efficiency with a low ROE of 1.27%
- The company has been able to generate a Return on Equity (avg) of 1.27% signifying low profitability per unit of shareholders funds
Company has a low Debt to Equity ratio (avg) at 0 times
Flat results in Sep 26
Stock is technically in a Bullish range
With ROE of 0.9, it has a Very Expensive valuation with a 4.9 Price to Book Value
Majority shareholders : Non Institution
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
INR 169 Cr (Micro Cap)
691.00
19
0.00%
-0.09
0.91%
4.85
Total Returns (Price + Dividend) 
Achyut Healthcar for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Achyut Healthcare Ltd is Rated Hold by MarketsMOJO
Achyut Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Achyut Healthcare Ltd is Rated Hold by MarketsMOJO
Achyut Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Achyut Healthcare Ltd Upgraded to Hold as Technicals Improve and Financials Show Promise
Achyut Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 22 Oct 2026, is driven primarily by a shift in technical trends, positive quarterly financial results, and a stabilising valuation despite some lingering concerns over management efficiency and profitability metrics.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
27-Oct-2026 | Source : BSESubmission of Newspaper Publication of Financial Statement for the quarter and half year ended September 30 2026.
Board Meeting Outcome for Outcome Of Board Meeting
26-Oct-2026 | Source : BSEOutcome of Board Meeting
Unaudited Result September 2026
26-Oct-2026 | Source : BSEUnaudited Result September 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Achyut Healthcare Ltd has announced 1:10 stock split, ex-date: 10 Dec 24
Achyut Healthcare Ltd has announced 4:10 bonus issue, ex-date: 10 Dec 24
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (5.13%)
Mahendra Chatrabhuj Raycha (11.01%)
Dharam Prakash Tripathi (15.87%)
42.84%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is -46.96% vs -28.70% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -64.29% vs 133.33% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 513.04% vs -56.81% in Mar 2025
Growth in half year ended Sep 2025 is 15.00% vs -42.86% in Mar 2025
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 90.24% vs 20.70% in Sep 2026
YoY Growth in nine months ended Dec 2025 is -42.50% vs 29.03% in Sep 2026
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 280.00% vs -50.33% in Mar 2025
YoY Growth in year ended Mar 2026 is -37.25% vs 2.00% in Mar 2025